Highlights The Precision Peptide Company’s newly launched direct-to-consumer and telehealth platform is now available in all 50 states of the United States. 100% U.S.-compounded peptide products are supported through a 503A compounding agreement. July 23, 2026, is the scheduled FDA advisory committee review date for several peptide substances, including BPC-157. The Precision Peptide Company’s compounding, telehealth, compliance, and consumer-sales infrastructure are currently in place. The website brings together oral supplements, transdermal patches, topical products, and telehealth services through one consumer-facing platform. The transdermal patches provide a differentiated, needle-free format that requires no mixing or cold storage. LegitScript Healthcare Merchant Certification supports compliance, consumer safety, payment processing, and advertising standards. The launch is extended to expand retail reach and brand visibility as the business advances its commercial rollout. Vancouver, British Columbia–(Newsfile Corp. – July 21, 2026) – The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the “Company” or “BPC”), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announced the launch of its direct-to-consumer retail and telehealth website across all 50 U.S. states.
This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.
Brief Summary
The Precision Peptide Company is thrilled to announce the launch of its new direct-to-consumer retail and telehealth platform, now available nationwide in all 50 U.S. states. This innovative website showcases a range of 100% U.S.-compounded peptide products, including oral supplements, transdermal patches, and topical solutions.
- Seamless Access: Consumers can now easily access peptide products anywhere in the U.S.
- Quality Assurance: All products are supported by a 503A compounding agreement.
- Needle-Free Innovation: Our transdermal patches provide a user-friendly alternative that requires no mixing or storage.
With LegitScript Healthcare Merchant Certification, we ensure compliance and safety in your purchases. As we advance our commercial rollout, this platform aims to enhance our retail reach and brand visibility. Why it matters: The launch positions The Precision Peptide Company as a leader in wellness products accessible directly to consumers.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.